TRANSCATHETER AORTIC VALVE REPLACEMENT IN BICUSPID AORTIC VALVE DISEASE
نویسندگان
چکیده
منابع مشابه
Transcatheter Aortic Valve Replacement: A Review Article
Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...
متن کاملTranscatheter Aortic Valve Replacement
With the worldwide number of TAVR procedures rapidly approaching 200,000, coupled with an amassed knowledge spanning over a decade, we are able to now reflect on the evolution of TAVR and how changes in technology, operator/institution experience, and patient selection have ultimately affected clinical outcomes. With this in mind, in this issue of JACC: Cardiovascular Interventions, Beohar et a...
متن کاملTranscatheter Aortic-Valve Replacement.
Case History: A 77-year-old man presents with fatigue and shortness of breath with minimal exertion. He is brought into the examination room in a wheelchair due to shortness of breath with ambulation. He has a history of hypertension, diabetes mellitus, and coronary artery disease with prior stent to left anterior descending artery. Examination is notable for a harsh III/VI late-peaking systoli...
متن کاملOutcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis.
BACKGROUND Transcatheter aortic valve replacement (TAVR) is being increasingly performed in patients with bicuspid aortic valve stenosis (AS). OBJECTIVES This study sought to compare the procedural and clinical outcomes in patients with bicuspid versus tricuspid AS from the Bicuspid AS TAVR multicenter registry. METHODS Outcomes of 561 patients with bicuspid AS and 4,546 patients with tricu...
متن کاملTranscatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis Using Lotus Valve System.
Bicuspid aortic stenosis (BAS) has been excluded in clinical trials on transcatheter aortic valve replacement (TAVR) due to the presumed uneven expansion of the aortic prosthesis, leading to significant paravalvular regurgitation (PVR). There is no transcatheter heart valve (THV) commercially approved for treating BAS. The Lotus Valve System mitigates PVR by possessing an adaptive seal and bein...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2014
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(14)61942-2